Is It Time To Buy Northwest Biotherapeutics (NWBO) Stock?
On Monday, Northwest Biotherapeutics (OTCMKTS: NWBO) had an 8.59% increase, creating the largest rise in the past two months. The company has not yet released the top-line data of its phase III trial of DCVax®-L, so, should investors buy the stock now?
Amsden Lindsay - July 20, 2021
Is Northwest Biotherapeutics (NWBO) Stock Worth To Buy?
Northwest Biotherapeutics (OTCMKTS: NWBO) stock experienced a short rise and fall process in the middle of last month. Although the stock fell by 2.5% so far this year, it is trying to recover.
InvestReader Editor - June 13, 2021